In Small Doses: Arsenic

This is a short movie, made by Dartmouth College in 2009, about the risks associated with exposure to potentially harmful amounts of arsenic in private well water, particularly in New Hampshire and New England.

Nutritional Epigenetics

This little video beautifully explains the concept of nutritional epigenetics. Working with international researchers, we published in 2013 a review on this topic:

Jalili M, Pati S, Rath B, Bjørklund G, Singh RB. Effect of Diet and Nutrients on Molecular Mechanism of Gene Expression Mediated by Nuclear Receptor and Epigenetic Modulation. Open Nutra J 2013;6:27-34.

The Interwoven Global Epidemics of Mercury Toxicity and Autism

In October 2017, Robert F. Kennedy Jr. published an article on the website of the World Mercury Project about one of CONEM’s studies (1). Kennedy is the son of former New York senator and U.S. attorney general Robert F. Kennedy and nephew of former President John F. Kennedy. He is an attorney, environmental activist and syndicated talk radio host. 

The Interwoven Global Epidemics of Mercury Toxicity and Autism

Metals wreak havoc on living systems, including humans, animals and plants alike. RFK, Jr. discusses a new review article in Environmental Research and pulls together a wide body of literature with the aim of summing up current research and emerging trends about the global epidemics of toxicity and autism.

Reference

1. Bjørklund G, Dadar M, Mutter J, Aaseth J. The toxicology of mercury: Current research and emerging trends. Environ Res 2017; 159: 545-554.

 

Dental Amalgams and Chronic Disease

Working with a team of American researchers, we published in 2014 a review about the association between dental amalgams and chronic disease (1). The following is a summary:

“The purpose of this review is to examine the evidence for a relationship between mercury (Hg) exposure from dental amalgams and certain idiopathic chronic illnesses–chronic fatigue syndrome (CFS), fibromyalgia (FM), depression, anxiety, and suicide. Dental amalgam is a commonly used dental restorative material that contains approximately 50% elemental mercury (Hg0) by weight and releases Hg0 vapor. Studies have shown that chronic Hg exposure from various sources including dental amalgams is associated with numerous health complaints, including fatigue, anxiety, and depression–and these are among the main symptoms that are associated with CFS and FM. In addition, several studies have shown that the removal of amalgams is associated with improvement in these symptoms. Although the issue of amalgam safety is still under debate, the preponderance of evidence suggests that Hg exposure from dental amalgams may cause or contribute to many chronic conditions. Thus, consideration of Hg toxicity may be central to the effective clinical investigation of many chronic illnesses, particularly those involving fatigue and depression.”

– Geir Bjørklund

Reference

1. Kern JK, Geier DA, Bjørklund G, King PG, Homme KG, Haley BE, Sykes LK, Geier MR. Evidence supporting a link between dental amalgams and chronic illness, fatigue, depression, anxiety, and suicide. Neuro Endocrinol Lett 2014; 35: 537-552.

The Rise of the Antibiotic-Resistant Superbug

Infographic of the antibiotic-resistant diseases.

Zinc, Copper, and Autism Spectrum Disorder

Joint Research

Research indicates that children with autism spectrum disorder (ASD) appear to be at risk for zinc (Zn) deficiency, copper (Cu) toxicity, and often disturbed metallothionein system functioning (1-4). Working with international researchers, the following is a summary of our work.

Li et al. (2014) investigated the serum levels of Zn and Cu in 60 Chinese children with ASD (48 boys, 12 girls) and a control group of 60 healthy sex-matched and age-matched individuals (2). The researchers also evaluated the autism severity using the Childhood Autism Rating Scale (CARS) score. The mean serum Zn levels and Zn/Cu ratio in the study were significantly lower in the ASD children compared with the control group (P<0.001). At the same, the serum Cu levels were significantly higher in the ASD children compared with the control group (P<0.001). It was in the study found a significant negative association between the Zn/Cu ratio and CARS scores (r=-0.345, P=0.007) (2).

Macedoni-Lukšič et al. (2015) determined the serum levels of Zn and Cu in a group of Slovenian children with ASD (N = 52, average age = 6.2 years) and a control group of children with other neurological disorders (N = 22, average age = 6.6 years), matched in terms of intellectual abilities (3). Compared to the control group, the ASD group had significantly elevated serum Cu/Zn ratio (95% confidence interval for children with ASD=1.86-2.26; 95% confidence interval for the control group=1.51-1.88) (3).

Crăciun et al. (2016) investigated the levels of Zn and Cu in whole blood, as well as the Cu/Zn ratio in a group of 28 Romanian ASD children. No significant difference in whole blood Cu was observed. However, Cu/Zn ratio was ~15 % (p = 0.008) higher in ASD children than that in the control ones. The results of the study may be indicative of Zn deficiency in ASD children (4).

In conclusion, our research suggests that providing Zn to ASD children may be an important component of a treatment protocol, especially in children with Zn deficiency (1-4). Mercury accumulation may occur as a cause or consequence of metallothionein dysfunction in ASD children, which may be one of the causes of Zn deficiency. Metallothioneins are proteins with important functions in metal metabolism and protection. It is important to monitor and follow the values for both Cu and Zn together during Zn therapy because these two trace elements are both antagonists in function, and essential for living cells (1).

– Geir Bjørklund

 

References

1. Bjørklund G. The role of zinc and copper in autism spectrum disorders. Acta Neurobiol Exp 2013; 73: 225–236.

2. Li SO, Wang JL, Bjørklund G, Zhao WN, Yin CH. Serum copper and zinc levels in individuals with autism spectrum disorders. Neuroreport 2014; 25: 1216-1220.

3. Macedoni-Lukšič M, Gosar D, Bjørklund G, Oražem J, Kodrič J, Lešnik-Musek P, Zupančič M, France-Štiglic A, Sešek-Briški A, Neubauer D, Osredkar J. Levels of metals in the blood and specific porphyrins in the urine in children with autism spectrum disorders. Biol Trace Elem Res 2015; 163: 2-10.

4. Crăciun EC, Bjørklund G, Tinkov AA, Urbina MA, Skalny AV, Rad F, Dronca E. Evaluation of whole blood zinc and copper levels in children with autism spectrum disorder. Metab Brain Dis 2016; 31: 887-890.

New Environmental Initiative in Semey, Kazakhstan: The Former Testing Site for the Soviet Union’s Nuclear Weapons

Council for Nutritional and Environmental Medicine (CONEM) has groups in different parts of the world. One of these is CONEM Kazakhstan Environmental Health and Safety Research Group. In June 2017, this group was established at the Semey State Medical University to promote environmental studies. Until 2007 Semey was known as Semipalatinsk. The Semipalatinsk Test Site was the primary testing venue for the Soviet Union’s nuclear weapons. It is located on the steppe in northeast Kazakhstan, south of the valley of the Irtysh River. The head of the CONEM group in Kazakhstan is associate professor Lyudmila Pivina, MD, PhD.

In memoriam Vera Stejskal

I’m very sorry to announce that my good friend and collaborator Professor Vera Stejskal (Stockholm University, Stockholm, Sweden and MELISA Medica Foundation) has recently passed away. She was a pioneer in the field of immunotoxicology, and the inventor of the MELISA test. I have very good memories of Vera, and we had good contact with each other for about 30 years. I remember especially the MELISA conference in Valencia in 2009, where I had lovely days together with Vera, her two daughters, and other friends. She was one of the first members of the Council for Nutritional and Environmental Medicine (CONEM). Also, I had the honor to collaborate with Vera on two research papers about metal intolerance in rheumatic disorders (1, 2). In loving memory of Vera Stejskal, my thoughts go, especially to her family.

Geir Bjørklund

 

References

1. Stejskal V, Ockert K, Bjørklund G. Metal-induced inflammation triggers fibromyalgia in metal-allergic patients. Neuro Endocrinol Lett 2013; 34: 559-565.

2. Stejskal V, Reynolds T, Bjørklund G. Increased frequency of delayed type hypersensitivity to metals in patients with connective tissue disease. J Trace Elem Med Biol 2015; 31: 230-236.

External link

In memoriam Vera Stejskal, inventor of MELISA testing. October 13, 2017. http://www.melisa.org/2017/10/13/in-memoriam-vera-stejskal

 

Healing of Amyotrophic Lateral Sclerosis: A Case Report

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive and fatal neurodegenerative disease that causes selective motor neuron death. Mercury toxicity has been suggested as a possible risk factor for ALS and other neurodegenerative disorders.

Three of the members of the CONEM Germany Environmental Health and Safety Research Group published this case report recently in the peer-reviewed journal Complementary Medicine Research.

 

Inge Mangelsdorf, Harald Walach, and Joachim Mutter

Healing of Amyotrophic Lateral Sclerosis: A Case Report

Complement Med Res 2017; 24(3): 175-181

 

ABSTRACT

Background: Amyotrophic lateral sclerosis (ALS) is a devastating disease leading to death within 3–5 years in most cases. New approaches to treating this disease are needed. Here, we report a successful therapy.

Case Report: In a 49-year-old male patient suffering from muscle weakness and fasciculations, progressive muscular atrophy, a variant of ALS, was diagnosed after extensive examinations ruling out other diseases. Due to supposed mercury exposure from residual amalgam, the patient’s teeth were restored. Then, the patient received sodium 2,3-dimercaptopropanesulfate (DMPS; overall 86 × 250 mg in 3 years) in combination with α-lipoic acid and followed by selenium. In addition, he took vitamins and micronutrients and kept a vegetarian diet. The excretion of metals was monitored in the urine. The success of the therapy was followed by scoring muscle weakness and fasciculations and finally by electromyography (EMG) of the affected muscles. First improvements occurred after the dental restorations. Two months after starting therapy with DMPS, the mercury level in the urine was increased (248.4 µg/g creatinine). After 1.5 years, EMG confirmed the absence of typical signs of ALS. In the course of 3 years, the patient recovered completely.

Conclusions: The therapy described here is a promising approach to treating some kinds of motor neuron disease and merits further evaluation in rigorous trials.

 

Petition for the Release of Publicly Funded Research Data in the US on Mercury and Infants

Kaiser Permanente in the US used public funding to collect data and conduct a study on infants and mercury exposure. In their study, which had serious methodological flaws, they purportedly found that mercury exposure is safe for infants.

Mercury Free Baby has requested the data from Kaiser Permanente, but even after repeated requests and even though taxpayer dollars funded the study, they refuse to release the data for other researchers to check the results.

Infants are exposed to mercury from several sources, such as their mother’s mercury fillings, flu shots containing mercury, ingesting mercury-containing fish, and from inhaling coal power plant emissions. Approximately 630,000 infants are born every year in the US with high levels of mercury in their blood. Numerous studies show that mercury has detrimental effects on child development.

Kaiser Permanente has a conflict of interest on this matter because they promote a policy that exposes pregnant women to mercury through flu shots given during pregnancy and so they have a vested interest in finding mercury exposure in infants to be safe. The Kaiser Permanente study which purports that mercury exposure is safe for infants has the potential to influence public policy, and that would be bad for our children.

Please sign the petition requesting that Kaiser Permanente releases this data to the researchers.

This petition will be delivered to:
Tracy A. Lieu, MD, MPH, Director, Division of Research, Kaiser Permanente, Oakland, CA, USA